Abbvie to acquire Allergan for $63 billion
Abbvie has agreed to buy Irish drugmaker Allergan, with Kirkland & Ellis and Weil Gotshal & Manges advising on antitrust.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10